Finance

Sonoma tops off series A as it builds broader Treg therapy pipeline 

Janssen vet Dragone hired as CMO 

With an extra $30 million in series A funding, Sonoma is expanding the range of indications for its immunosuppressive Treg cell therapy pipeline, and exploring combination